Sign in
  Edit search
Caspofungin versus liposomal amphotericin B for empirical an…
Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia
Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia
Article, Chapter
Authors: T.J. Walsh
Publication: New England Journal of Medicine, Volume:351, Issue:14, Page(s):1391-1402
Published: Massachusetts Medical Society, 2004
ISSN: 0028-4793
  Full text availability for this item
View Full Text Source:New England Journal of Medicine,New England Journal of Medicine,Massachusetts Medical Society Opens in new Window
Journal:  New England Journal of Medicine Source:Massachusetts Medical Society Opens in new Window
Collection:  Massachusetts Medical Society Opens in new Window
Coverage:
  • 1990~present; volume:322~present;issue:1~present
View Full Text Source:New England Journal of Medicine,New England Journal of Medicine,Journals@Ovid Opens in new Window
Journal:  New England Journal of Medicine Source:Journals@Ovid Opens in new Window
Collection:  Journals@Ovid Opens in new Window
Coverage:
  • 1990-01~present; volume:322~present;issue:1~present
View Full Text Source:New England Journal of Medicine,New England Journal of Medicine,Westlaw Journals and Law Reviews - Nijmegen Opens in new Window
Journal:  New England Journal of Medicine Source:Westlaw Journals and Law Reviews - Nijmegen Opens in new Window
Collection:  Westlaw Journals and Law Reviews - Nijmegen
Coverage:
  • 1985~present
Browse related articles
  Print copies at your library
Check availability in RUQuest
  Request a copy of this item
Cite this item